bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

Author's Avatar
Feb 13, 2023

bioAffinity+Technologies%2C+Inc. (NASDAQ: BIAF; BIAFW) today announced its commercialization team, including the addition of Julie Anne Overton, a veteran of print and broadcast journalism, corporate communications and federal public affairs, as bioAffinity Technologies’ Director of Communications, and the marketing and advertising firms of Havas+Health+%26amp%3B+You and Trinity+Life+Sciences to help build the CyPath® Lung brand and position it for success in the cancer diagnostics sector.